Psych News Alert | FDA (3)

FDA Issues Draft Guidance for Conducting Clinical Trials With Psychedelic Substances

6/27/23 12:00 AM

FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease

5/11/23 12:00 AM

The U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...

Memantine May Reduce Symptoms of Hair-Pulling, Skin-Picking Disorder

2/22/23 12:00 AM

FDA Approves Second Monoclonal Antibody Medication for Alzheimer’s

1/9/23 12:00 AM

FDA Approves Novel Rapid-Acting Oral Antidepressant

8/22/22 12:00 AM

FDA Issues Warning About Dental Risk With Transmucosal Buprenorphine

1/14/22 12:00 AM

Caplyta Approved for Bipolar Depression in Adults

12/20/21 12:00 AM

Today Is Deadline to Recertify in Modified Clozapine REMS, Re-enroll Patients

11/15/21 12:00 AM

FDA Narrows Use of New Alzheimer’s Drug to Early Stage Patients

7/9/21 12:00 AM